Tremfya
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Tremfya in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Tremfya.
48
Global Revenue Ranking
19
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Tremfya
Psoriatic arthritis can develop in up to 30% of people with psoriasis
The drug is the first IL-23 inhibitor approved for children from the age of six
Approximately 125 million people globally are living with some form of psoriasis
Inflammatory bowel disease is estimated to affect more than 500,000 people in the UK
More than 2.5 million people in Europe are affected by the inflammatory bowel disease
More than 2.5 million people in Europe are living with the inflammatory bowel disease
The inflammatory condition affects approximately 30% of psoriasis patients
Approximately 25% of cases are diagnosed during childhood or adolescence
Inflammatory bowel disease is estimated to affect nearly two million people across Europe
An estimated three million people in the US are affected by inflammatory bowel disease
Tremfya, Stelara and Darzalex have been recommended for ulcerative colitis, Crohn’s disease and multiple myeloma, respectively
Inflammatory bowel disease affects almost one in every 100 people in the US
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology